SABESTOMIG

UNII:	X79QP2R2CZ
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	SABESTOMIG
GSRS Full Record:	X79QP2R2CZ i

2648346-74-9
Immunoglobulin G1 [239-phenylalanine,240-glutamic acid,336-serine,354-cysteine,371-serine,373-alanine,412-valine], bispecific, anti-(human programmed cell death protein 1) (human-Mus musculus clone LO115 γ1-chain) disulfide with human-Mus musculus clone LO115 κ-chain, bis(disulfide) with immunoglobulin G1 [131-cysteine,225-cysteine,239-phenylalanine,240-glutamic acid,336-serine,359-cysteine,371-tryptophan] anti-(human T-cell immunoglobulin and mucin domain-containing protein 3) (human-Mus musculus clone O13-1 γ1-chain) disulfide with [123-cysteine,213-valine] human-Mus musculus clone O13-1 λ-chain
Immunoglobulin G1-kappa/lambda, anti-[Homo sapiens PDCD1 (programmed cell death 1, PD1, PD-1, CD279) and HAVCR2 (hepatitis A virus cellular receptor 2, T cell immunoglobulin and mucin domains family member 3, TIM3, TIM-3, TIMD3, CD366)], humanized and Homo sapiens monoclonal antibody, bispecific, bivalent
Sabestomig
sabestomig [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SABESTOMIG

Synonyms and Mappings

Resources